Picture loading failed.

Pre-Made Tosatoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

osatoxumab is a fully-human monoclonal antibody (IgG1λ) targeting the Staphylococcus aureus alpha-toxin or the S. aureus alpha-hemolysin 1,2,3 and thereby preserving human immune cells by protecting against destruction of host cells mediated by the toxin.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-589-1mg 1mg 3090
GMP-Bios-ab-589-10mg 10mg Inquiry
GMP-Bios-ab-589-100mg 100mg Inquiry
GMP-Bios-ab-589-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Tosatoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody
INN Name Tosatoxumab
TargetToxin A
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCLambda
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2013
Year Recommended2014
CompaniesAridis Pharmaceuticals;Kenta Biotech
Conditions Approvedna
Conditions ActiveNosocomial pneumonia
Conditions DiscontinuedSepsis
Development Techna